Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Carbazochrome Sodium Sulfonate Injection
- Product Name
- 卡络磺钠注射液
- Approval Number
- 国药准字H20254455
- Approval Date
- Jun 3, 2025
NMPA
Beclometasone Dipropionate Suspension for Inhalation
- Product Name
- 吸入用丙酸倍氯米松混悬液
- Approval Number
- 国药准字H20254113
- Approval Date
- May 13, 2025
NMPA
Aspirin Enteric-coated Tablets
- Product Name
- 阿司匹林肠溶片
- Approval Number
- 国药准字H20249600
- Approval Date
- Dec 1, 2024
NMPA
Phloroglucinol Injection
- Product Name
- 间苯三酚注射液
- Approval Number
- 国药准字H20249143
- Approval Date
- Oct 22, 2024
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 吸入用布地奈德混悬液
- Approval Number
- 国药准字H20244894
- Approval Date
- Sep 19, 2024
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20243677
- Approval Date
- May 15, 2024
NMPA
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20243061
- Approval Date
- Jan 16, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20234645
- Approval Date
- Dec 13, 2023
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20083826
- Approval Date
- Jul 21, 2023
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydroch1oride Oral solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20233217
- Approval Date
- Feb 21, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found